Leucine-Rich alpha-2 Glycoprotein 1 (LRG1) (N-Term) Peptide
LRG1
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN979557
150,78 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination:
France
Envoi sous 15 à 22 jours ouvrables
Aperçu rapide pour Leucine-Rich alpha-2 Glycoprotein 1 (LRG1) (N-Term) Peptide (ABIN979557)
Antigène
LRG1
(Leucine-Rich alpha-2 Glycoprotein 1 (LRG1))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Séquence
- GVTLSPKDCQ VFRSDHGSSI SCQPPAEIPG YLPADTVHLA VEFFNLTHLP
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-LRG1 Antibody(ARP52475_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LRG1 (Leucine-Rich alpha-2 Glycoprotein 1 (LRG1))
-
Sujet
-
The leucine-rich repeat (LRR) family of proteins, including LRG1, have been shown to be involved in protein-protein interaction, signal transduction, and cell adhesion and development. LRG1 is expressed during granulocyte differentiation (O'Donnell et al., 2002 [PubMed 12223515]).
Alias Symbols: HMFT1766, LRG
Protein Interaction Partner: FN1
Protein Size: 347 -
Poids moléculaire
- 38 kDa
-
ID gène
- 116844
-
NCBI Accession
- NM_052972, NP_443204
-
UniProt
- P02750
Antigène
-
Vous êtes ici:
